Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Transverse Myelitis Clinical Presentation and Management

Clinical Presentation

  • Patients with transverse myelitis typically develop spastic paralysis with increased deep tendon reflexes rather than flaccid paralysis, as the condition primarily affects the spinal cord causing upper motor neuron damage 1
  • Transverse myelitis presents with acute or subacute bilateral weakness or sensory changes, often accompanied by increased deep tendon reflexes due to the upper motor neuron involvement 1

Pathophysiology and Neurological Findings

  • Transverse myelitis affects the spinal cord gray matter, leading to upper motor neuron damage above the level of the lesion 2
  • This upper motor neuron involvement results in spastic paralysis with hyperreflexia (increased reflexes) rather than the flaccid paralysis and hyporeflexia seen in lower motor neuron disorders 1
  • MRI findings typically show T2-weighted hyperintense lesions in the spinal cord that may appear wedge-shaped on axial views and cigar-shaped on sagittal views 2

Differential Considerations

  • Guillain-Barré syndrome (GBS) presents with flaccid paralysis and reduced/absent reflexes due to peripheral nerve involvement 3
  • Poliomyelitis and other enterovirus infections can cause an encephalitis with acute flaccid paralysis 4

Diagnostic Approach

  • Neurologic consultation should be obtained promptly 1
  • MRI of the spine with thin axial cuts through the region of suspected abnormality is essential 1
  • Lumbar puncture should be performed to check cell count, protein, glucose, oligoclonal bands, viral PCRs, and onconeural antibodies 1
  • Blood tests should include B12, HIV, RPR, ANA, Ro/La, TSH, and aquaporin-4 IgG to rule out other causes 1
  • Evaluation for urinary retention and constipation is important as these are common autonomic manifestations 1

Clinical Course and Management

  • First-line treatment typically includes high-dose intravenous corticosteroids (methylprednisolone 1g/day for 3-5 days) 1
  • For moderate to severe cases, additional therapies such as intravenous immunoglobulin (IVIG) should be strongly considered 1
  • In refractory cases, plasma exchange therapy or rituximab may be beneficial 5

Important Clinical Pearls

  • The presence of increased deep tendon reflexes is a key distinguishing feature of transverse myelitis compared to conditions with flaccid paralysis 1
  • Longitudinally extensive transverse myelitis (affecting ≥3 vertebral segments) should raise suspicion for neuromyelitis optica spectrum disorder (NMOSD) 2